TENET HEALTHCARE CORP · General Medical & Surgical Hospitals, NEC

THC

Low riskNext report: Due any day

View price ↗

The short version

A profitable company with steady sales.

Going well

Profitable
Brings in more cash than it spends
Buying back shares: share count down 18% in 3 years

Watch out for

High debt: 3.1x equity

Money moves

No insider buying or selling in the last 30 days
Institutions cut 1.7% from their holdings in the quarter ending June 2026 (323 bought, 359 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$268.96+0.2% that day

Company value: $32.9B; Share price times all shares
Price vs profit (P/E): 10.4x; You pay about $10 for each $1 of yearly profit
Price vs sales: 1.5x; Company value is 1.5 times a year of sales
Cash vs value: 7%; Cash as a share of company value
Debt vs value: 40%; Debt as a share of company value

From THC's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$5.6B+6.8% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $21.8B, up 5.4% from the 12 months before. Over 5 years, sales grew about 3.9% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of THC. Starting points are the company's recent numbers.

Sales growth+5% a yearRecently: +5.4% a yearProfit margin15%Last 12 months: 14.6%P/E at the end10xToday: 10.4x. Many steady companies trade at 12x to 25xShare count change-5% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$27.8B

Profit in 5 years$4.2B

Price these guesses point to$440.70+64% vs $268.96 todayAbout +10% a year, before dividends

What today's price needs: with a 15% margin and a 10x P/E, sales could shrink about 4.9% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Word of mouth

Updated daily

People looking up the company, yesterday: 2.1x normal; 172 views vs about 83 on a usual day

Forum talk counts mentions of THC in popular online stock forums, a slice of the internet rather than all of it. Company lookups show interest in the company itself, which can come from news that isn't about the stock. Attention isn't quality.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/6Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.56.4%
MissDebt under half of equityNot relying on borrowed money.3.10x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.11.1%
MissProfitable every yearSteady profits, not one good year.9 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$2.5B
PassShare count not growingNot diluting owners. Falling means buybacks.-17.8% in 3 years

Revenue: $21.3B; +3.1% vs prior year
5-year growth: +3.9%/yr; revenue, per year
Total debt: $13.1B; 3.10x equity
Current ratio: 1.76x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.